Chargement de la fiche…
Chargement de la fiche…
Photo : TouN, CC BY-SA 3.0, Wikimedia Commons
Vous êtes Dre Anne Peretz ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dre Anne Peretz est rhumatologue à Mouriès (13890). Elle consulte à CABINET DU DR Anne PERETZ, CENTRE DEVENSON — ROUTE DE MAUSSANE, 13890 Mouriès. Elle est conventionnée en secteur 1 et accepte la carte Vitale.
Consulter
CABINET DU DR Anne PERETZ
CENTRE DEVENSON — ROUTE DE MAUSSANE, 13890 Mouriès
Libéral
Dre Anne Peretz, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
Rhumatologie (SM) — Diplôme d'études spécialisées
Diplôme éq d'un pays de l'EEE profession Médecin · DEES Rhumatologie — Capacité / certificat d'études spéciales
Les plus citées
2002The Journal of clinical endocrinology and metabolism282 citations
A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis
2005Arthritis research & therapy81 citations
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
1989The Journal of rheumatology61 citations
Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment
En bref
Dre Anne Peretz consulte à CABINET DU DR Anne PERETZ, CENTRE DEVENSON — ROUTE DE MAUSSANE, 13890 Mouriès. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 04 90 47 57 25 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Oui, en secteur 1 : tarifs conventionnés, sans dépassement d'honoraires (source : Assurance Maladie).
Oui. Source : Assurance Maladie.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Mouriès →Rhumatologues en Bouches-du-Rhône (13) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Mouriès, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Unusual localisation of chronic arthropathy in lumbar facet joints after parvovirus B19 infection
2015Revue medicale de BruxellesPubMed
[The secondary prevention of osteoporosis needs a multidisciplinary approach]
2002The Journal of clinical endocrinology and metabolismPubMed
A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis
1999Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAPubMed
Efficiency of quantitative ultrasound measurements as compared with dual-energy X-ray absorptiometry in the assessment of corticosteroid-induced bone impairment
1998Revue medicale de BruxellesPubMed
[Evaluation of the cost of non-hormonal treatment of osteoporosis]
1996MaturitasPubMed
Cyclical pamidronate infusions in postmenopausal osteoporosis
1995International journal of fertility and menopausal studiesPubMed
Overview of the clinical usefulness of bone mineral measurements in the prevention of postmenopausal osteoporosis
1992Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USAPubMed
Risk of osteoporosis in men with chronic bronchitis
1991Revue medicale de BruxellesPubMed
[Cortisone-induced osteoporosis: from physiopathogenesis to treatment]
1989The Journal of rheumatologyPubMed
Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment
2017Ugeskrift for laegerPubMed
[Rheumatoid arthritis and hand surgery]
2006Arthritis research & therapyPubMed
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
2005Rheumatology (Oxford, England)PubMed
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
2005Arthritis research & therapyPubMed
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
2001Scandinavian journal of rheumatologyPubMed
Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial
1992British journal of rheumatologyPubMed
Adjuvant treatment of recent onset rheumatoid arthritis by selenium supplementation: preliminary observations
1991Nuclear medicine communicationsPubMed
Oesophageal involvement in rheumatoid arthritis patients: a study with oesophageal radionuclide transit using 81Krm
1989Journal of trace elements and electrolytes in health and diseasePubMed
Effects of chronic and acute corticosteroid therapy on zinc and copper status in rheumatoid arthritis patients
1989Clinical rheumatologyPubMed
Osteocalcin and bone mineral content in rheumatoid arthritis
2009The Journal of dermatological treatmentPubMed
Infliximab-induced acne: a new case and review of published reports
2006Arthritis research & therapyPubMed
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
2005Rheumatology (Oxford, England)PubMed
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
2005Arthritis research & therapyPubMed
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
1992Biological trace element researchPubMed
Effects of acute prednisolone administration on plasma and liver copper in rats with adjuvant arthritis
1991Agents and actionsPubMed
Effects of acute and chronic prednisolone treatment on serum zinc levels in rats with adjuvant arthritis
1991International journal of tissue reactionsPubMed
Effects of chronic prednisolone administration on plasma copper in rats with adjuvant arthritis
1989International journal of tissue reactionsPubMed
Comparison of effects of chronic inflammation and long-term prednisolone administration on zinc metabolism in rats
2007Revue medicale de BruxellesPubMed
[Inflammatory low back pain]
2007Clinical and experimental rheumatologyPubMed
Low back pain as presenting manifestation of giant cell arteritis associated to abdominal aortitis
2005Journal of clinical pharmacy and therapeuticsPubMed
Long-term tolerability of tramadol LP, a new once-daily formulation, in patients with osteoarthritis or low back pain
2021Clinical and experimental rheumatologyPubMed
Galectin-3-binding protein is a novel predictor of venous thromboembolism in systemic lupus erythematosus
1998British journal of rheumatologyPubMed
Unusual high frequency of multifocal lesions of osteonecrosis in a young patient with systemic lupus erythematosus
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.